Nafarelin Acetate

醋酸那法瑞林

Report date: 2022/09/14 17:29:19
NME

Base Information

Drug NameNafarelin Acetate
Drug Alias NameNafarelinum那法瑞林NafarelinaSynarelSynral +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsPelvic PainPuberty, PrecociousEndometriosis
Global Approved IndicationsPuberty, Precocious
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/02/13
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesNational Center For Complementary And Integrative Health
Active IndicationsPuberty, Precocious
Inactive IndicationsPelvic PainEndometriosis

Other Information

ATC CodeH01CA02
Related LinksWikipediaDrugBankKEGG